Literature DB >> 8623489

A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.

C Brattström1, G Tydén, J Säwe, G Herlenius, K Claesson, C G Groth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8623489

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  [Systemic immunosuppressives after penetrating keratoplasty].

Authors:  A Reis; F Birnbaum; T Reinhard
Journal:  Ophthalmologe       Date:  2007-05       Impact factor: 1.059

Review 2.  [Immunosuppressives to prevent rejection reactions after allogeneic corneal transplantation].

Authors:  T Lapp; P Maier; F Birnbaum; G Schlunck; T Reinhard
Journal:  Ophthalmologe       Date:  2014-03       Impact factor: 1.059

Review 3.  Immunosuppressive drugs in paediatric liver transplantation.

Authors:  I D van Mourik; D A Kelly
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  Acute sirolimus overdose: a multicenter case series.

Authors:  Alessandro Ceschi; Elja Heistermann; Sonja Gros; Cornelia Reichert; Hugo Kupferschmidt; Nicholas R Banner; Stephan Krähenbühl; Anne B Taegtmeyer
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

5.  Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury.

Authors:  Qingyu Zhou; Justin Doherty; Antonina Akk; Luke E Springer; Ping Fan; Ivan Spasojevic; Ganesh V Halade; Huanghe Yang; Christine T N Pham; Samuel A Wickline; Hua Pan
Journal:  Nanomaterials (Basel)       Date:  2022-01-21       Impact factor: 5.076
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.